Data / Form D filings / Pulmotect, Inc.
Pulmotect, Inc.: Form D filings
Pulmotect, Inc., a biotechnology company in Houston, TX, filed 12 Form D notices with the SEC between 2016 and 2024. The latest, on September 9, 2024, reports $10.3 million sold of an offering with no set size to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3900 ESSEX LANE, SUITE 575, Houston, TX, 77027
- Phone
- (713) 579-9226
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Texas
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1673929
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 9, 2024 | New notice | Indefinite | $10,280,435 | 15 | Aug 30, 2024 | sec.gov | |
| Jan 16, 2024 | Amendment | Indefinite | $3,661,000 | 11 | Jan 26, 2022 | sec.gov | |
| Sep 28, 2023 | Amendment | Indefinite | $1,500,000 | 2 | May 31, 2023 | sec.gov | |
| Jun 14, 2023 | New notice | Indefinite | $300,000 | 1 | May 31, 2023 | sec.gov | |
| Feb 10, 2023 | Amendment | Indefinite | $3,511,000 | 11 | Jan 26, 2022 | sec.gov | |
| Jan 27, 2023 | Amendment | Indefinite | $3,511,000 | 11 | Jan 26, 2022 | sec.gov | |
| Feb 9, 2022 | New notice | Indefinite | $2,211,000 | 3 | Jan 26, 2022 | sec.gov | |
| Mar 11, 2021 | New notice | $3,500,000 | $3,500,000 | 21 | Mar 5, 2021 | sec.gov | |
| Feb 24, 2020 | Amendment | Indefinite | $6,099,391 | 22 | Feb 23, 2018 | sec.gov | |
| Feb 26, 2019 | Amendment | Indefinite | $5,544,392 | 15 | Feb 23, 2018 | sec.gov | |
| Mar 7, 2018 | New notice | Indefinite | $4,000,003 | 1 | Feb 23, 2018 | sec.gov | |
| May 6, 2016 | New notice | $2,500,250 | $1,751,430 | $748,820 | 5 | Apr 5, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kumar E. Srinivasan | Director | |
| Magnus E. Hook | Director | |
| Atul E. Varadhachary | Director | |
| Colin E. Broom | Executive Officer, Director | |
| Bruce E. Given | Director | |
| Leo E. Linbeck | Director | |
| Brenton E. Scott | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Sep 9, 2024 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Pulmotect, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.